Your browser doesn't support javascript.
loading
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.
Bednasz, Cindy J; Venuto, Charles S; Ma, Qing; Daar, Eric S; Sax, Paul E; Fischl, Margaret A; Collier, Ann C; Smith, Kimberly Y; Tierney, Camlin; Acosta, Edward P; Mager, Donald E; Morse, Gene D.
Afiliação
  • Bednasz CJ; AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA amabile@buffalo.edu.
  • Venuto CS; AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Ma Q; Center for Health + Technology, University of Rochester, Rochester, New York, USA.
  • Daar ES; AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Sax PE; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, California, USA.
  • Fischl MA; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Collier AC; University of Miami School of Medicine, Miami, Florida, USA.
  • Smith KY; University of Washington School of Medicine and Harborview Medical Center, Seattle, Washington, USA.
  • Tierney C; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • Acosta EP; Statistical Data Analysis Center, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Mager DE; Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Morse GD; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
Antimicrob Agents Chemother ; 63(4)2019 04.
Article em En | MEDLINE | ID: mdl-30642925
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos